SBHMY sino biopharmaceutical - trd205 granted breakthrough therapy designation by China's cde after phase II trial for cpsnp
SBHMY sino biopharmaceutical - trd205 granted breakthrough therapy designation by China's cde after phase II trial for cpsnp
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.